Evidence map›Paper›PMID 41721281›Full record

ArticleBMC public health2026

Clinic-based prevalence of uncorrected refractive errors and associated visual impairment: a nationwide cross-sectional study of 3.6 million outpatients in Mexico.

Abraham García-Gil, Beatriz Itzel Hernández-Jurado, Marco Antonio Luna-Ruiz-Esparza, Perla Lorena Ayón-Sicaeros, Eduardo Espinoza-Angulo, Héctor Machado-Jiménez, Humberto Gómez-Campaña, Linda Nasser-Nasser, Abraham Campos-Romero, Jonathan Alcántar-Fernández

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abraham García-GilInnovation and Research Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Beatriz Itzel Hernández-JuradoOptometry Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Marco Antonio Luna-Ruiz-EsparzaInnovation and Research Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Perla Lorena Ayón-SicaerosOptometry Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Eduardo Espinoza-AnguloOptometry Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Héctor Machado-JiménezOptometry Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Humberto Gómez-CampañaMedical Direction, Salud Digna, Culiacan, 80184, Mexico.
Linda Nasser-NasserMedical Direction, Visión Cirugía Ambulatoria S.C, Monterrey, 64710, Nuevo Leon, Mexico.
Abraham Campos-RomeroInnovation and Research Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico.
Jonathan Alcántar-FernándezInnovation and Research Department, Salud Digna, Culiacan, 80184, Sinaloa, Mexico. jonathan.alcantar@salud-digna.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUncorrected refractive errors (UREs) are the predominant cause of vision impairment and blindness worldwide, despite the availability of eyeglasses as a cost-effective intervention. Sociocultural factors, including restricted access to healthcare and inadequate self-care education, exacerbate the burden of UREs. There is a paucity of studies evaluating UREs in Mexico with comprehensive national coverage across various age groups. This clinic-based study aimed to assess the profile of UREs and associated visual impairment (VI) in Mexico using a substantial sample of individuals seeking care at a large nationwide outpatient network.

methodsWe evaluated UREs and URE-related VI by analyzing eye examination data from 3.6 million outpatients who attended Salud Digna clinics in 2024.

resultsThe national clinic-based prevalence of UREs was 26.5% (980,718 affected individuals, 95% CI:26.5%-26.59%), highest in Baja California Sur state (6,515 affected individuals, 43.8%, 95% CI:42.99%-44.59%), among males aged 40-49 years (71,002 affected individuals, 34.1%, 95% CI:33.91%-34.32%), and females under 10 years (17,132 affected individuals, 32.3%, 95% CI:31.88%-32.67%). Clinic-based prevalence of uncorrected astigmatism, uncorrected hyperopia, uncorrected hyperopia-astigmatism, uncorrected myopia, and uncorrected myopia-astigmatism were 1.3% (48,978 affected individuals, 95% CI:1.31%-1.34%), 10.2% (376,701 affected individuals, 95% CI:10.16%-10.23%), 1.7% (61,171 affected individuals, 95% CI:1.64%-1.67%), 6.4% (235,285 affected individuals, 95% CI:6.34%-6.39%), and 7% (258,583 affected individuals, 95% CI:6.97%-7.02%), with highest rates in Tlaxcala (444 affected individuals, 3.9%, 95% CI:3.54%-4.26%), Tabasco (10,235 affected individuals, 20%, 95% CI:19.66%-20.35%), Baja California Sur (673 affected individuals, 4.5%, 95% CI:4.2%-4.87%), Zacatecas (3,149 affected individuals, 10.2%, 95% CI:9.85%-10.52%), and Tlaxcala (1,504 affected individuals, 13.17%, 95% CI:12.55%-13.8%). The national URE-related VI clinic-based prevalence was 0.89% (32,962 affected individuals, 95% CI:0.88%-0.9%), highest in Hidalgo state (527 affected individuals, 1.8%, 95% CI:1.63%-1.93%) and among those over 80 years (1,457 affected males, 6%, 95% CI:5.97%-6.59%; 2,206 affected females, 5.8%, 5.83%-6.33%). The national clinic-based prevalence of mild, moderate, and severe visual impairment was 0.62% (22,858 affected individuals, 95% CI:0.61%-0.63%), 0.26% (9,683, 95% CI:0.26%-0.27%), and 0.01% (421 affected individuals, 95% CI:0.01%-0.01%).

conclusionsThis outpatient-based study highlights the clinic-based prevalence of UREs and related VI in Mexico, emphasizing the need for improved access to eye care services.

Indexed as

OutpatientsRefractive ErrorsVision DisordersAdolescentAdultAgedChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleMexicoMiddle AgedPrevalenceAstigmatismHyperopia.MyopiaUncorrected refractive errors

Identifiers

PMID41721281
PMCPMC13032544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.